iX Biopharma inks agreement to supply medicinal cannabis wafer to the Australian market
SINGAPORE: Specialty pharmaceutical company iX Biopharma Ltd announced that its wholly-owned subsidiary, iX Syrinx has formalised a supply agreement with Cannatrek Medical Pty Ltd, a wholly-owned subsidiary of Cannatrek Ltd. Cannatrek is a medicinal cannabis enterprise with a national distribution network in Australia and participates heavily in doctor and patient education programmes for medicinal cannabis….